Comment on: Anti-acid therapy in SSc-associated interstitial lung disease: long-term outcomes from the German Network for Systemic Sclerosis-caution is key in interpreting retrospective data: Reply

Rheumatology (Oxford). 2023 Dec 1;62(12):e351-e352. doi: 10.1093/rheumatology/kead313.
No abstract available

MeSH terms

  • Humans
  • Lung
  • Lung Diseases, Interstitial* / drug therapy
  • Lung Diseases, Interstitial* / etiology
  • Retrospective Studies
  • Scleroderma, Systemic* / complications
  • Scleroderma, Systemic* / drug therapy